Kalyra Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Kalyra Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199 (NCT03880487) | Kalyra Pharmaceuticals, Inc. | 2019-03-12 |
Track Kalyra Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.